Global Human Rabies Vaccine Market Research Report 2021

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,900	119 Pages	QYResearch Group	April, 2021	QYR16606791

Best Price Guarantee
Price	from $2,900
Length	119 Pages
Publisher	QYResearch Group
Published Date	April, 2021
SKU	QYR16606791

Global Human Rabies Vaccine Market Research Report 2021

Summary

In 2020, the global Human Rabies Vaccine market size was US$ 1030 million and it will reach US$ 1360 million in 2027, growing at CAGR of 4.3% between 2021 and 2027.

This report focuses on Human Rabies Vaccine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Human Rabies Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, etc.

Global Human Rabies Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
By Company
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals

Segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells

Segment by Application
Post-exposure
Pre-exposure

By Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Other Regions

Europe
Germany
U.K.
France
Italy
Russia
Rest of Europe

South America
Brazil
Rest of South America

Middle East & Africa
Middle East
Africa

1 HUMAN RABIES VACCINE MARKET OVERVIEW: 1.1 Product Overview and Scope of Human Rabies Vaccine; 1.2 Human Rabies Vaccine Segment by Type; 1.2.1 Global Human Rabies Vaccine Sales Growth Rate Comparison by Type (2020-2027); 1.2.2 Vero Cell Rabies Vaccine; 1.2.3 BHK Rabies Vaccine; 1.2.4 Chick Embryo Cell Rabies Vaccine; 1.2.5 Human Diploid Cells Rabies Vaccine; 1.3 Human Rabies Vaccine Segment by Application; 1.3.1 Global Human Rabies Vaccine Sales Comparison by Application (2021-2027); 1.3.2 Post-exposure; 1.3.3 Pre-exposure; 1.4 Global Human Rabies Vaccine Market Size Estimates and Forecasts; 1.4.1 Global Human Rabies Vaccine Revenue 2016-2027; 1.4.2 Global Human Rabies Vaccine Sales 2016-2027; 1.4.3 Human Rabies Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 HUMAN RABIES VACCINE MARKET COMPETITION BY MANUFACTURERS: 2.1 Global Human Rabies Vaccine Sales Market Share by Manufacturers (2019-2020); 2.2 Global Human Rabies Vaccine Revenue Market Share by Manufacturers (2019-2020); 2.3 Global Human Rabies Vaccine Average Price by Manufacturers (2019-2020); 2.4 Manufacturers Human Rabies Vaccine Manufacturing Sites, Area Served, Product Type; 2.5 Human Rabies Vaccine Market Competitive Situation and Trends; 2.5.1 Human Rabies Vaccine Market Concentration Rate; 2.5.2 The Global 5 Largest Human Rabies Vaccine Players Market Share by Revenue; 2.5.3 Global Human Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3); 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HUMAN RABIES VACCINE RETROSPECTIVE MARKET SCENARIO BY REGION: 3.1 Global Human Rabies Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021; 3.2 Global Human Rabies Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021; 3.3 North America Human Rabies Vaccine Market Facts & Figures by Country; 3.3.1 North America Human Rabies Vaccine Sales by Country; 3.3.2 North America Human Rabies Vaccine Revenue by Country; 3.3.3 United States; 3.3.4 Canada; 3.3.5 Mexico; 3.4 Europe Human Rabies Vaccine Market Facts & Figures by Country; 3.4.1 Europe Human Rabies Vaccine Sales by Country; 3.4.2 Europe Human Rabies Vaccine Revenue by Country; 3.4.3 Germany; 3.4.4 U.K.; 3.4.5 France; 3.4.6 Italy; 3.4.7 Russia; 3.5 Asia Pacific Human Rabies Vaccine Market Facts & Figures by Region; 3.5.1 Asia Pacific Human Rabies Vaccine Sales by Region; 3.5.2 Asia Pacific Human Rabies Vaccine Revenue by Region; 3.5.3 China; 3.5.4 Japan; 3.5.5 South Korea; 3.5.6 India; 3.5.7 Southeast Asia; 3.6 South America Human Rabies Vaccine Market Facts & Figures by Country; 3.6.1 South America Human Rabies Vaccine Sales by Country; 3.6.2 South America Human Rabies Vaccine Revenue by Country; 3.6.3 Brazil; 3.7 Middle East and Africa Human Rabies Vaccine Market Facts & Figures by Country; 3.7.1 Middle East and Africa Human Rabies Vaccine Sales by Country; 3.7.2 Middle East and Africa Human Rabies Vaccine Revenue by Country; 3.7.3 Middle East; 3.7.4 Africa
4 HUMAN RABIES VACCINE HISTORIC MARKET ANALYSIS BY TYPE: 4.1 Global Human Rabies Vaccine Sales Market Share by Type (2016-2021); 4.2 Global Human Rabies Vaccine Revenue Market Share by Type (2016-2021); 4.3 Global Human Rabies Vaccine Price by Type (2016-2021)
5 HUMAN RABIES VACCINE HISTORIC MARKET ANALYSIS BY APPLICATION: 5.1 Global Human Rabies Vaccine Sales Market Share by Application (2016-2021); 5.2 Global Human Rabies Vaccine Revenue Market Share by Application (2016-2021); 5.3 Global Human Rabies Vaccine Price by Application (2016-2021)
6 KEY COMPANIES PROFILED: 6.1 Bharat Biotech; 6.1.1 Bharat Biotech Corporation Information; 6.1.2 Bharat Biotech Description and Business Overview; 6.1.3 Bharat Biotech Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.1.4 Bharat Biotech Human Rabies Vaccine Product Portfolio; 6.1.5 Bharat Biotech Recent Developments/Updates; 6.2 Bavarian Nordic; 6.2.1 Bavarian Nordic Corporation Information; 6.2.2 Bavarian Nordic Description and Business Overview; 6.2.3 Bavarian Nordic Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.2.4 Bavarian Nordic Human Rabies Vaccine Product Portfolio; 6.2.5 Bavarian Nordic Recent Developments/Updates; 6.3 Sanofi-Pasteur; 6.3.1 Sanofi-Pasteur Corporation Information; 6.3.2 Sanofi-Pasteur Description and Business Overview; 6.3.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.3.4 Sanofi-Pasteur Human Rabies Vaccine Product Portfolio; 6.3.5 Sanofi-Pasteur Recent Developments/Updates; 6.4 Chengda; 6.4.1 Chengda Corporation Information; 6.4.2 Chengda Description and Business Overview; 6.4.3 Chengda Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.4.4 Chengda Human Rabies Vaccine Product Portfolio; 6.4.5 Chengda Recent Developments/Updates; 6.5 KANGH; 6.5.1 KANGH Corporation Information; 6.5.2 KANGH Description and Business Overview; 6.5.3 KANGH Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.5.4 KANGH Human Rabies Vaccine Product Portfolio; 6.6 Prcmise; 6.6.1 Prcmise Corporation Information; 6.6.2 Prcmise Description and Business Overview; 6.6.3 Prcmise Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.6.4 Prcmise Human Rabies Vaccine Product Portfolio; 6.6.5 Prcmise Recent Developments/Updates; 6.7 Henan Grand Biopharma; 6.7.1 Henan Grand Biopharma Corporation Information; 6.7.2 Henan Grand Biopharma Description and Business Overview; 6.7.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.7.4 Henan Grand Biopharma Human Rabies Vaccine Product Portfolio; 6.8 Zhuoyi Biological; 6.8.1 Zhuoyi Biological Corporation Information; 6.8.2 Zhuoyi Biological Description and Business Overview; 6.8.3 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.8.4 Zhuoyi Biological Human Rabies Vaccine Product Portfolio; 6.9 ZhongKe Biopharm; 6.9.1 ZhongKe Biopharm Corporation Information; 6.9.2 ZhongKe Biopharm Description and Business Overview; 6.9.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.9.4 ZhongKe Biopharm Human Rabies Vaccine Product Portfolio; 6.10 Ningbo Rongan Biological; 6.10.1 Ningbo Rongan Biological Corporation Information; 6.10.2 Ningbo Rongan Biological Description and Business Overview; 6.10.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.10.4 Ningbo Rongan Biological Human Rabies Vaccine Product Portfolio; 6.11 Indian Immunologicals; 6.11.1 Indian Immunologicals Corporation Information; 6.11.2 Indian Immunologicals Description and Business Overview; 6.11.3 Indian Immunologicals Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021); 6.11.4 Indian Immunologicals Human Rabies Vaccine Product Portfolio; 6.11.5 Indian Immunologicals Recent Developments/Updates
7 HUMAN RABIES VACCINE MANUFACTURING COST ANALYSIS: 7.1 Human Rabies Vaccine Key Raw Materials Analysis; 7.1.1 Key Raw Materials; 7.1.2 Key Suppliers of Raw Materials; 7.2 Proportion of Manufacturing Cost Structure; 7.3 Manufacturing Process Analysis of Human Rabies Vaccine; 7.4 Human Rabies Vaccine Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS: 8.1 Marketing Channel; 8.2 Human Rabies Vaccine Distributors List; 8.3 Human Rabies Vaccine Customers
9 HUMAN RABIES VACCINE MARKET DYNAMICS: 9.1 Human Rabies Vaccine Industry Trends; 9.2 Human Rabies Vaccine Growth Drivers; 9.3 Human Rabies Vaccine Market Challenges
10 GLOBAL MARKET FORECAST: 10.1 Human Rabies Vaccine Market Estimates and Projections by Type; 10.1.1 Global Forecasted Sales of Human Rabies Vaccine by Type (2022-2027); 10.1.2 Global Forecasted Revenue of Human Rabies Vaccine by Type (2022-2027); 10.2 Human Rabies Vaccine Market Estimates and Projections by Application; 10.2.1 Global Forecasted Sales of Human Rabies Vaccine by Application (2022-2027); 10.2.2 Global Forecasted Revenue of Human Rabies Vaccine by Application (2022-2027); 10.3 Human Rabies Vaccine Market Estimates and Projections by Region; 10.3.1 Global Forecasted Sales of Human Rabies Vaccine by Region (2022-2027); 10.3.2 Global Forecasted Revenue of Human Rabies Vaccine by Region (2022-2027)
11 RESEARCH FINDINGS AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE: 12.1 Methodology/Research Approach; 12.1.1 Research Programs/Design; 12.1.2 Market Size Estimation; 12.1.3 Market Breakdown and Data Triangulation; 12.2 Data Source; 12.2.1 Secondary Sources; 12.2.2 Primary Sources; 12.3 Author List; 12.4 Disclaimer
List of Tables: Table 1. Global Human Rabies Vaccine Sales (K Unit) Growth Rate Comparison by Type (2020-2027); Table 2. Global Human Rabies Vaccine Sales (K Unit) Comparison by Application (2021-2027); Table 3. Rabies Postexposure Prophylaxis Schedule; Table 4. Global Human Rabies Vaccine Market Size by Region (US$ Million): 2016 VS 2021 VS 2027; Table 5. Key Manufacturers Human Rabies Vaccine Covered in This Study; Table 6. Global Human Rabies Vaccine Sales (K Unit) of Key Manufacturers (2019-2020); Table 7. Global Human Rabies Vaccine Sales Market Share by Manufacturers (2019-2020); Table 8. Global Human Rabies Vaccine Revenue (US$ Million) by Manufacturers (2019-2020); Table 9. Global Human Rabies Vaccine Revenue Share by Manufacturers (2019-2020); Table 10. Global Market Human Rabies Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2020); Table 11. Manufacturers Human Rabies Vaccine Manufacturing Sites and Area Served; Table 12. Manufacturers Human Rabies Vaccine Product Type; Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI); Table 14. Global Human Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccine as of 2019); Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans; Table 16. Global Human Rabies Vaccine Sales by Region (2016-2021) & (K Unit); Table 17. Global Human Rabies Vaccine Sales Market Share by Region (2016-2021); Table 18. Global Human Rabies Vaccine Revenue by Region (2016-2021) & (US$ Million); Table 19. Global Human Rabies Vaccine Revenue Market Share by Region (2016-2021); Table 20. North America Human Rabies Vaccine Sales by Country (2016-2021) & (K Unit); Table 21. North America Human Rabies Vaccine Sales Market Share by Country (2016-2021); Table 22. North America Human Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million); Table 23. North America Human Rabies Vaccine Revenue Market Share by Country (2016-2021); Table 24. Europe Human Rabies Vaccine Sales by Country (2016-2021) & (K Unit); Table 25. Europe Human Rabies Vaccine Sales Market Share by Country (2016-2021); Table 26. Europe Human Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million); Table 27. Europe Human Rabies Vaccine Revenue Market Share by Country (2016-2021); Table 28. Asia Pacific Human Rabies Vaccine Sales by Region (2016-2021) & (K Unit); Table 29. Asia Pacific Human Rabies Vaccine Sales Market Share by Region (2016-2021); Table 30. Asia Pacific Human Rabies Vaccine Revenue by Region (2016-2021) & (US$ Million); Table 31. Asia Pacific Human Rabies Vaccine Revenue Market Share by Region (2016-2021); Table 32. South America Human Rabies Vaccine Sales by Country (2016-2021) & (K Unit); Table 33. South America Human Rabies Vaccine Sales Market Share by Country (2016-2021); Table 34. South America Human Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million); Table 35. South America Human Rabies Vaccine Revenue Market Share by Country (2016-2021)